Remineralization Potential of Nanostrontium/Fluoride Hydroxyapatite on Artificial Enamel Caries
Oral Sciences Reports · 2024
DOI: 10.12982/osr.2024.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Sciences Reports, 2024. Verfasst von Natcha Boontanapibul und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Objectives
This study aimed to evaluate the remineralization efficacy of nano-strontium/ fluoride hydroxyapatite paste on initial enamel caries in comparison with other remineralization products under a simulated pH-cycling model.
Methods
Following the artificial caries induction, forty enamel specimens with noncavitated lesion in the same range of lesion depth were selected by mean of micro-CT evaluation. The specimens were block-randomized into four experimental groups regarding remineralizing pastes: 1500 ppm sodium fluoride paste, 10%wt nano-hydroxyapatite paste, 10%wt nano-strontium/fluoride hydroxyapatite paste and 5%wt nano-strontium/ fluoride hydroxyapatite paste. Remineralizing effect was evaluated using micro-CT, while SEM/EDS line scan mode facilitated the investigation of remineralization patterns. Changes in lesion depth (ΔLD) and changes in mineral loss (ΔΔZ) were evaluated at 7 and 14 days of treatment under the pH-cycling model. Statistical analyses were performed using 2-way ANOVA and post hoc Tukey’s test (p
Zitieren
APA
Boontanapibul, N., & Kunawarote, S. (2024). Remineralization Potential of Nanostrontium/Fluoride Hydroxyapatite on Artificial Enamel Caries. Oral Sciences Reports. https://doi.org/10.12982/osr.2024.029
Vancouver
Boontanapibul N, Kunawarote S. Remineralization Potential of Nanostrontium/Fluoride Hydroxyapatite on Artificial Enamel Caries. Oral Sciences Reports. 2024. doi:10.12982/osr.2024.029
BibTeX
@article{Boontanapibul2024,
author = {Boontanapibul, Natcha and Kunawarote, Sitthikorn},
title = {Remineralization Potential of Nanostrontium/Fluoride Hydroxyapatite on Artificial Enamel Caries},
journal = {Oral Sciences Reports},
year = {2024},
doi = {10.12982/osr.2024.029}
}
EUVIMED